Industry News

LigoLab Applauded by Frost & Sullivan for Transforming Diagnostic Laboratories with its All-in-One Integrated LIS & RCM Platform

SAN ANTONIO, Jan. 18, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the North American Laboratory Information Systems Industry and recognizesLigoLab  as the 2022 Competitive Strategy Leadership Award winner for improving the efficiency of diagnostic laboratories and transforming them int...

2022-01-18 21:00 2278

CN Energy Signs Operation & Management Agreement; Enters Multi-Billion Dollar Pharmaceutical Excipients Market

LISHUI, China, Jan. 18, 2022 /PRNewswire/ -- CN Energy Group. Inc. (the "Company") today announced that its subsidiary Hangzhou Forasen Technology Co., Ltd. signed an operation and management ("O&M") agreement (the "Agreement") with HuaiNan JiaHe New Materials Co., Ltd. ("JiaHe") and JiaHe's acti...

2022-01-18 21:00 2361

I-Mab Announces First Patient Dosed in China Phase 2 Combination Trial of Lemzoparlimab with Toripalimab in Patients with Advanced Solid Tumors

SHANGHAI and GAITHERSBURG, Md., Jan. 18, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed in itsChina phase ...

2022-01-18 21:00 2137

Farmmi Builds on International Growth with Repeat Customer Order

LISHUI, China, Jan. 18, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier inChina, today announced the Company's subsidiary Zhejiang Farmmi Biotechnology Co., Ltd., won another follow-on product order. The latest order for dried Shiitak...

2022-01-18 21:00 3783

Stamus Networks Announces Availability of Suricata Language Server

Open-source tool helps Suricata signature developers with syntax checking and auto-completion INDIANAPOLIS and PARIS, Jan. 18, 2022 /PRNewswire/ -- Stamus Networks, a global provider of high-performance network threat detection and response systems, today announced the general availability of Su...

2022-01-18 20:55 1728

Akeso's AK117 (CD47 monoclonal antibody) in Combination with AK112 (PD-1/VEGF bi-specific antibody) to Initiate a Phase Ib/II Clinical Trial with or without Chemotherapy for the Treatment of Advanced Malignant Tumors

HONG KONG, Jan. 18, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) announces that Ligufalimab (CD47 monoclonal antibody, research and development code: AK117), the novel immuno-oncology drug independently developed by the Company, combined with Ivonescimab (PD-1/VEGF bi-specific antibody, research an...

2022-01-18 20:44 2675

Sungrow Launches "1+X" Modular Inverter at World Future Energy Summit, 2022

ABU DHABI, UAE, Jan. 18, 2022 /PRNewswire/ -- Sungrow, the global leading inverter solution supplier for renewables, officially launches the brand-new central inverter -- "1+X" Modular Inverter at World Future Energy Summit, a high-profile international event for global sustainability and transit...

2022-01-18 20:34 2853

Intersec 5G-ready geolocation platform accelerates positioning use case enablement

PARIS, Jan. 18, 2022 /PRNewswire/ -- Intersec (or the "Company"), a global leader in mobility and activity data solutions, announced the acceleration of the adoption of its 5G-ready geolocation platform by tier-one carriers around the world, enabling them to monetize new 5G positioning use cases,...

2022-01-18 20:30 2978

Omdia Releases the Enhanced All-Optical Metro Network White Paper, Illustrating How All-Optical Metro Target Network Helps Operators Reduce Costs and Increase Revenues

LONDON, Jan. 18, 2022 /PRNewswire/ -- Omdia and Huawei jointly released The Enhanced All-Optical Metro Network (the white paper for short). The white paper defines an all-optical metro target network as featuring simplified, deterministic, scalable, intelligent, and always-on attributes. Accordin...

2022-01-18 20:16 1880

Clarivate Patent Trend Report Shows Increasing Business Focus on Innovation Through Patent Portfolio Spend

Global organizations cite patent innovation as key to increasing competitive advantage amidst the pandemic LONDON, Jan. 18, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new re...

2022-01-18 20:09 2489

Servier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline

- Consolidated revenue of €4.725 billion, up +4.3% at constant rates (+0.8% at current rates) - Revenue for brand-name medicines of €3.306 billion +4.8% at constant rates (+0.6% at current rates) and €1.419 billion for the generics +2.9% at constant rates (+1.1% at current rates) - An accelerat...

2022-01-18 20:00 2549

Farallon Reiterates Call on Toshiba to Rebuild Trust with Stakeholders Ahead of EGM Regarding Proposed Separation Plan

Farallon is deeply concerned by reports that Toshiba is considering a shareholder vote on the Separation Plan with a 50% approval threshold, rather than the 66 2/3% ultimately and legally required in 2023 Farallon calls on the Board to ensure a 66 2/3% approval threshold at the EGM in order to p...

2022-01-18 18:30 1784

BRANDS FOR GOOD AWARDS 2021-2022 SPOTLIGHTS ON ETHICS AND SUSTAINABILITY

* Bringing Authentic Ethical Voices of SMEs to the Limelight with This Year's Theme of "Your New Ethical Voice" * Surviving, Transforming, Thriving Through Brand Innovation and Digital Transformation Through Social Responsibility * Launch of Maybank-Brands for Good - "Partnership For Good" p...

2022-01-18 18:24 2617

Firmenich signs Strategic Partnership Agreement with HARMAY in China

GENEVA, Jan. 18, 2022 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, is proud to announce a new strategic partnership with HARMAY, a leading new retail brand in China. Under the agreement, Firmenich and HARMAY will join forces to contribute to the dev...

2022-01-18 18:14 3468

Ascletis Announces Signing of Ritonavir Tablet Purchase Agreement with Phokam Pharmaceutical Import-Export Co., Ltd of Laos

HANGZHOU and SHAOXING, China, Jan. 18, 2022 /PRNewswire/ -- Ascletis Pharma Inc. ("Ascletis") (HKEX: 1672) today announces signing of the ritonavir tablet purchase agreement between Phokam Pharmaceutical Import-Export Co., Ltd (as buyer) ofLaos and Ascletis Pharmaceuticals Co., Ltd. (as seller), ...

2022-01-18 18:00 3582

Pickle Crow Gold Project, Canada

KEY POINTS * Drilling of high-grade veins outside the Resource in the Shaft 1 and Shaft 3 areas continues to deliver significant intersections, including:  - 7.3m @ 33.3 g/t gold from 9.4m in AUDD0246 - 1.5m @ 35.2 g/t gold from 541.5m in AUDD0227 - 4.0m @ 11.0 g/t gold from 205.8m in AUDD024...

2022-01-18 17:38 2192

PANASONIC LAUNCHES PRIME+ EDITION REFRIGERATORS, PROMOTES WELLNESS THROUGH HEALTHY EATING

* Highest level of premium designed with purposeful functionality to enhance quality of life * Contemporary design with choice of gradient colours for glass facade models * nanoe™ X inhibits almost 99.99% of bacteria, reduces pesticide on vegetables, suppresses odours * PRIME FREEZE freeze...

2022-01-18 17:27 4050

CATL Launches Battery Swap Solution EVOGO Featuring Modular Battery Swapping

* CATL's subsidiary CAES has rolled out EVOGO, its innovative modular battery swap solution, which includes battery blocks, fast battery swap stations, and an app * EVOGO's features include high compatibility with vehicle models, need-based battery rental, and complementarity with fast chargi...

2022-01-18 17:24 5560

MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation

HANGZHOU, China, Jan. 18, 2022 /PRNewswire/ -- MindRank AI, an artificial intelligence (AI) driven biotech company, today announced that the company has nominated a preclinical candidate (PCC) for an important class B GPCR drug target, 8 Months After Program Initiation. Historically, the developm...

2022-01-18 17:17 1999

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials

WILMINGTON, Del., Jan. 18, 2022 /PRNewswire/ -- Novaliq GmbH, 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd. today announced the establishment of Dermaliq Therapeutics, Inc (Dermaliq), a newly formedDelaware -based pharmaceutical development company, and the signing of aUSD 1...

2022-01-18 17:00 2635